Dr. Shí Zhànx祥's Column Not Linked to IPO Filing; No Recent Prospectus Submission Found
Sep 18, 2015 18:56
CST Updated
18:56
Columnist: Shi Zhanxiang Dr. Shi Zhanxiang serves as the China Country Director for Physicians Worldwide and the Principal Investigator for NIH Clinical Research Projects in China. He is the Director of the Special Fund for the School of Clinical and Translational Medicine, established by the Chinese Medical Association and the China International Medical Foundation; he also serves as the Secretary-General and International Cooperation Coordinator for the “China-US International Forum on Clinical and Translational Medicine.”
Served as lead translator and editor for ten reference books in clinical and translational medicine, and established collaborations with international journals such as *Science*, *Nature*, and the *New England Journal of Medicine*. Research interests include clinical and translational medicine, mobile and telemedicine, medical research ethics, and intelligent medical robotics.
Article List
Doctor's Dilemma? Comparable Efficacy, Yet a 40-Fold Price Disparity
Where Is Big Data? — Analyzing Subpopulations of Patients with Type 2 Diabetes
“The Most Successful Business Model in ‘Mobile Health’—Side Notes from the 2015 U.S. Mobile Health Annual Conference (Part III)”
“Mobile Health” Was Born at the Wrong Time—Side Notes from the 2015 American Mobile Health Annual Conference (Part II)
Where Has Mobile Health “Moved” To? — Side Notes from the 2015 U.S. Mobile Health Annual Conference (Part I)
[Translational Medicine]: What Does It Mean That the UK Recommended President Xi to Visit Medical Robotics Technologies and Products?
[Translational Medicine] Do You Have a Brain That Helps You Succeed?
[Translational Medicine] Precision medicine stems from the collection and analysis of big data on disease and health, along with long-term follow-up.
Positioning of Telemedicine Robots: From Clinical Diagnosis to Enhancing Care Quality and Chronic Disease Management
A Major Step Forward in Realizing the Dream of “Precision Medicine”
Telemedicine: Segmenting Inelastic Demand to Better Leverage Advantages
The Latest Interpretation of “Precision Medicine”: Establishing a Large-Scale Research Collaboration Framework
Summary of the 2014 mHealth Summit—A Slight Sense of Being a Frog in a Well